Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
2.
Neurology ; 81(11): 1004-11, 2013 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-23430685

RESUMEN

OBJECTIVE: To discuss the American Academy of Neurology (AAN)'s Top Five Recommendations in the Choosing Wisely campaign promoting high-value neurologic medicine and physician-patient communication. The AAN published its Top Five Recommendations in February 2013 in collaboration with the American Board of Internal Medicine Foundation and Consumer Reports. METHODS: A Choosing Wisely Working Group of 10 AAN members was formed to oversee the process and craft the evidence-based recommendations. AAN members were solicited for recommendations, the recommendations were sent out for external review, and the Working Group members (article authors) used a modified Delphi process to select their Top Five Recommendations. RESULTS AND RECOMMENDATIONS: The Working Group submitted 5 neurologic recommendations to the AAN Practice Committee and Board of Directors; all 5 were approved by both entities in September 2012. Recommendation 1: Don't perform EEGs for headaches. Recommendation 2: Don't perform imaging of the carotid arteries for simple syncope without other neurologic symptoms. Recommendation 3: Don't use opioids or butalbital for treatment of migraine, except as a last resort. Recommendation 4: Don't prescribe interferon-ß or glatiramer acetate to patients with disability from progressive, nonrelapsing forms of multiple sclerosis. Recommendation 5: Don't recommend carotid endarterectomy for asymptomatic carotid stenosis unless the complication rate is low (<3%).


Asunto(s)
Manejo de la Enfermedad , Conciliación de Medicamentos/normas , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/terapia , Neurología/normas , Humanos , Neurología/organización & administración , Sociedades Médicas/organización & administración , Sociedades Médicas/normas , Estados Unidos
3.
J Occup Environ Med ; 53(10): 1187-93, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21926919

RESUMEN

OBJECTIVE: Beryllium mine and ore extraction mill workers have low rates of beryllium sensitization and chronic beryllium disease relative to the level of beryllium exposure. The objective was to relate these rates to the solubility and composition of the mine and mill materials. METHOD: Medical surveillance and exposure data were summarized. Dissolution of BeO, ore materials and beryllium hydroxide, Be(OH)(2) was measured in synthetic lung fluid. RESULT: The ore materials were more soluble than BeO at pH 7.2 and similar at pH 4.5. Be(OH)(2) was more soluble than BeO at both pH. Aluminum dissolved along with beryllium from ore materials. CONCLUSION: Higher solubility of beryllium ore materials and Be(OH)(2) at pH 7.2 might shorten particle longevity in the lung. The aluminum content of the ore materials might inhibit the cellular immune response to beryllium.


Asunto(s)
Contaminantes Ocupacionales del Aire/química , Beriliosis/etiología , Berilio/química , Hipersensibilidad/etiología , Minería , Enfermedades Profesionales/etiología , Exposición Profesional/efectos adversos , Solubilidad , Contaminantes Ocupacionales del Aire/efectos adversos , Contaminantes Ocupacionales del Aire/inmunología , Silicatos de Aluminio/efectos adversos , Silicatos de Aluminio/química , Silicatos de Aluminio/inmunología , Berilio/efectos adversos , Berilio/inmunología , Proliferación Celular , Células Cultivadas , Humanos , Linfocitos/efectos de los fármacos , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA